MOORHEAD — The Nutrition, Dietetics, and Exercise Science department at Concordia College is inviting adults ages 55 to 70 to a study examining how medication and lifestyle habits may influence cognitive function.
Led by Betsy Cogan, a registered dietitian nutritionist, the study focuses on people who are overweight or obese, or who are currently taking anti-obesity medications such as semaglutide, liraglutide, dulaglutide or exenatide.
The research aims to shed light on the growing use of GLP-1 receptor agonist medications and their possible cognitive benefits in aging adults, a Concordia news release said.
“It is clear that these types of medications produce meaningful weight loss and have several other health benefits that are now being shown in the literature; however, it remains unclear if such benefits extend to cognitive health,” Cogan said in the release.
Participants will undergo body measurements, a blood draw and cognitive assessments. They will also wear an activity-tracking device and complete a food and drink log over three days, the release said.
For their time, they will receive personalized health data including body composition, blood pressure, cholesterol and glucose levels and a detailed dietary analysis.
Participants may withdraw at any time, the release said.
For more information, contact Betsy Cogan at
or 218-299-3644.
Our newsroom occasionally reports stories under a byline of “staff.” Often, the “staff” byline is used when rewriting basic news briefs that originate from official sources, such as a city press release about a road closure, and which require little or no reporting. At times, this byline is used when a news story includes numerous authors or when the story is formed by aggregating previously reported news from various sources. If outside sources are used, it is noted within the story.